<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5C83B169-ED97-4A9C-8A39-033B5A151D0F"><gtr:id>5C83B169-ED97-4A9C-8A39-033B5A151D0F</gtr:id><gtr:name>University Hospital of Lille</gtr:name><gtr:address><gtr:line1>2, avenue Oscar Lambre</gtr:line1><gtr:postCode>F-59037</gtr:postCode><gtr:region>Scotland</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7B5B059B-D11D-4216-BAC4-CBFF7E5E3C2C"><gtr:id>7B5B059B-D11D-4216-BAC4-CBFF7E5E3C2C</gtr:id><gtr:name>Academic Medical Center</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E68501E9-4C3B-4A78-B85D-88EF2B577390"><gtr:id>E68501E9-4C3B-4A78-B85D-88EF2B577390</gtr:id><gtr:name>University of California, San Francisco</gtr:name><gtr:address><gtr:line1>50 Beale Street</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/19185705-3FB8-4C9C-B8F4-D5D7EA64F57F"><gtr:id>19185705-3FB8-4C9C-B8F4-D5D7EA64F57F</gtr:id><gtr:name>National Center for Biotechnology Information (NCBI)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/1529F791-0B6A-40F4-B05C-510DCB0DF8CB"><gtr:id>1529F791-0B6A-40F4-B05C-510DCB0DF8CB</gtr:id><gtr:name>Angioma Alliance</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/AE6EAB1A-CC2F-4FDB-A57F-41E76D78ACAB"><gtr:id>AE6EAB1A-CC2F-4FDB-A57F-41E76D78ACAB</gtr:id><gtr:name>Oxford University Hospitals NHS Trust</gtr:name><gtr:address><gtr:line1>Churchill Site</gtr:line1><gtr:line2>Old Road</gtr:line2><gtr:line3>Headington</gtr:line3><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX3 7LJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7"><gtr:id>055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7</gtr:id><gtr:name>London Sch of Hygiene and Trop Medicine</gtr:name><gtr:address><gtr:line1>Keppel Street</gtr:line1><gtr:postCode>WC1E 7HT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:department>Sch of Molecular. Genetics &amp; Pop Health</gtr:department><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5C83B169-ED97-4A9C-8A39-033B5A151D0F"><gtr:id>5C83B169-ED97-4A9C-8A39-033B5A151D0F</gtr:id><gtr:name>University Hospital of Lille</gtr:name><gtr:address><gtr:line1>2, avenue Oscar Lambre</gtr:line1><gtr:postCode>F-59037</gtr:postCode><gtr:region>Scotland</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7B5B059B-D11D-4216-BAC4-CBFF7E5E3C2C"><gtr:id>7B5B059B-D11D-4216-BAC4-CBFF7E5E3C2C</gtr:id><gtr:name>Academic Medical Center</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E68501E9-4C3B-4A78-B85D-88EF2B577390"><gtr:id>E68501E9-4C3B-4A78-B85D-88EF2B577390</gtr:id><gtr:name>University of California, San Francisco</gtr:name><gtr:address><gtr:line1>50 Beale Street</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/19185705-3FB8-4C9C-B8F4-D5D7EA64F57F"><gtr:id>19185705-3FB8-4C9C-B8F4-D5D7EA64F57F</gtr:id><gtr:name>National Center for Biotechnology Information (NCBI)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1529F791-0B6A-40F4-B05C-510DCB0DF8CB"><gtr:id>1529F791-0B6A-40F4-B05C-510DCB0DF8CB</gtr:id><gtr:name>Angioma Alliance</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AE6EAB1A-CC2F-4FDB-A57F-41E76D78ACAB"><gtr:id>AE6EAB1A-CC2F-4FDB-A57F-41E76D78ACAB</gtr:id><gtr:name>Oxford University Hospitals NHS Trust</gtr:name><gtr:address><gtr:line1>Churchill Site</gtr:line1><gtr:line2>Old Road</gtr:line2><gtr:line3>Headington</gtr:line3><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX3 7LJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7"><gtr:id>055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7</gtr:id><gtr:name>London Sch of Hygiene and Trop Medicine</gtr:name><gtr:address><gtr:line1>Keppel Street</gtr:line1><gtr:postCode>WC1E 7HT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/259AEBBF-4114-4CD4-B664-2BD42596F907"><gtr:id>259AEBBF-4114-4CD4-B664-2BD42596F907</gtr:id><gtr:firstName>Rustam</gtr:firstName><gtr:otherNames>Al-Shahi</gtr:otherNames><gtr:surname>Salman</gtr:surname><gtr:orcidId>0000-0002-2108-9222</gtr:orcidId><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G108%2F613"><gtr:id>9A7ADAF0-B076-43A0-92B6-B7E0BA4664FB</gtr:id><gtr:title>Prognosis and management of intracanial vascular malformations and non-traumatic intracerebral haemorrhage in adults</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G108/613</gtr:grantReference><gtr:abstractText>Haemorrhage into the brain - known as intracerebral haemorrhage, or ?ICH? for short - is a devastating condition, which kills one third of people within one month. For at least one quarter of adults with ICH, no cause is ever found. Of the known causes of ICH, abnormal tangles of blood vessels in the brain - known as intracranical vascular malformations, or IVMs for short - are the single most common cause of stroke due to ICH in young adults. IVMs can also leave young people disabled for life and cause epilepsy. The Scottish Intracranial Vascular Malformation Study (SIVMS) is the only study of every type of IVM based on a whole population, following adults from the time they are diagnosed. It will provide information for people with IVMs about their prognosis and the effects of treatment. It will also calculate the financial impact of IVMs and whether they are associated with conventional risk factors for blood vessel diseases.</gtr:abstractText><gtr:technicalSummary>Aims:

1. Resume recruitment and continue fellow-up of a unique prospective, population-based study of intracranial vascular malformations (IVMs), which are the commonest cause of haemorrhagic stroke in young adults, as well as a not uncommom cause of epilepsy: the scottish IVM study (SIVMS)

2. Begin a Lothian-wide study of the incidence, Causes and Haemostatic mechanisms in Primary Intracerebral Haemorrhage (LINCHPIN)

3. Complete my training in neurology and, as a consultant, support a clinical service for adults with IVMs in scotland



Objectives:

1. Systematic reveiws of the prognosis and treatment of IVMs and non-traumatic intracerebral haemorrhage

2. Resume recruitment to SIVMS and continue follow-up of the whole cohort to address aetiology, clinical presentation, prognosis, the effects of treatment, and economic burden

3. Form a network of UK AVM specialists, and create a simple database to use for clinical practice and research

4. Community based Lothian-wide cohort study of ICH (LINCHPIN): contemporary incidence, causes, prognosis for death and recurrent ICH, and whether microhaemorrhages &amp;amp; leukoaraiosis on MRI influence outcome



Design/methods: SIVMS is a prospective epidemiological cohort study, based on the whole adult population of Scotland. the study is built oupon successful, multidisciplinary, all-inclusive collaboration between radiologists, neurologists, stroke physicians, neurosurgeons and pathologists, and is steered by a committee representative of all four clinical features at presentation, and annual prospective follow-up data about a huge variety of outcomes and receipt of treatment (with any of surgical excision, endovascular embolisation, and stereotactic radiosurgery). LINCHPIN will be a prospective, community-based cohort study using similar case ascertainment as well as a hot pursuit model involving early clinical assessment, consent, blood sample collection and MRI brain scanning.



Scientific/Medical opportunities: SIVMS is a unique study, poised to address the long-term prognosis of IVMs. ICH and IVMs are of particular interest now because of their detection is likely to be rising with the widespread availability and uptake of brain imaging. Now is the time to assess the influence on ICH incidence and Prognosis of abnormalities such as microhaemorrhages and leukoaraiosis which are increasingly recognised on MRI, as well as recent strategies for secondary prevention of vascular events, and the decline of routine surgical evaculation of ICH.</gtr:technicalSummary><gtr:fund><gtr:end>2011-02-28</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-11-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>905254</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Angioma Alliance</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>USA Angioma Alliance Scientific Advisory Board</gtr:description><gtr:id>017F2E94-7789-4F3D-A606-022172B75BF9</gtr:id><gtr:impact>Publication of guidelines for the definition of haemorrhage from cerebral cavernous malformations</gtr:impact><gtr:outcomeId>54562243004e13.39860115-1</gtr:outcomeId><gtr:partnerContribution>Access to network of researchers and opportunity to create consensus guidelines</gtr:partnerContribution><gtr:piContribution>Advice on scientific strategy. Authoring of guidance documents</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Center for Biotechnology Information (NCBI)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Collaboration with the Microbleed Study Group</gtr:description><gtr:id>0FF3FBC9-5735-4979-B3F1-1433682EDD0F</gtr:id><gtr:impact>Publication of review in Lancet Neurology, Pub Med ID 19161908</gtr:impact><gtr:outcomeId>D720E016112-1</gtr:outcomeId><gtr:partnerContribution>Culminated in publication</gtr:partnerContribution><gtr:piContribution>Contribution to writing a manuscript</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Neurology</gtr:department><gtr:description>Collaboration with Institute of Neurology</gtr:description><gtr:id>6AD12DFE-606E-46E4-9845-9ADD5DF72B0C</gtr:id><gtr:impact>Co-applicant on successful programme grant application to the BHF</gtr:impact><gtr:outcomeId>SmpTMhYHwMc-1</gtr:outcomeId><gtr:partnerContribution>Collaboration on current studies and obtaining funding for future research studies,</gtr:partnerContribution><gtr:piContribution>Intellectual input</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Harvard University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Neurobiology</gtr:department><gtr:description>Collaboration with Boston Haemorrhagic Stroke Research Programme</gtr:description><gtr:id>77140108-8F3C-404A-BCFD-1FBD9DF2074E</gtr:id><gtr:impact>MRC senior clinical fellowship application</gtr:impact><gtr:outcomeId>eQrT5zKVowX-1</gtr:outcomeId><gtr:partnerContribution>Their collaboration has underpinned the development of my senior clinical fellowship application to MRC</gtr:partnerContribution><gtr:piContribution>I have generated the hypotheses, and designed the research programme</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Lille University Hospital</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:department>Department of Neurology</gtr:department><gtr:description>Collaboration with Lille haemorrhagic stroke group</gtr:description><gtr:id>FCC44D23-7176-45C9-9649-0D22163C7480</gtr:id><gtr:impact>Several publications</gtr:impact><gtr:outcomeId>mt6UHSBQzAR-1</gtr:outcomeId><gtr:partnerContribution>Several publications using shared data</gtr:partnerContribution><gtr:piContribution>Supervision of a postgraduate student, sharing data, leading on analyses</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>London School of Hygiene and Tropical Medicine (LSHTM)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Faculty of Epidemiology and Population Health</gtr:department><gtr:description>Collaboration with LSHTM</gtr:description><gtr:id>CB949E1C-D6BF-4FED-AECF-BB4843E1C201</gtr:id><gtr:impact>Paper published in BMJ. Springboard to further grant application, in collaboration with University of Nottingham</gtr:impact><gtr:outcomeId>ocK4CK8PPn3-1</gtr:outcomeId><gtr:partnerContribution>Sub-study of a large, international randomised controlled trial</gtr:partnerContribution><gtr:piContribution>Design of a sub-study, successful application for HTA funding, and analysis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Public Health and Primary Care</gtr:department><gtr:description>Collaboration with the MRC Cognitive Function and Ageing Study</gtr:description><gtr:id>C73AB549-C481-48D5-852C-B9A4DDE5DC22</gtr:id><gtr:impact>None so far</gtr:impact><gtr:outcomeId>DMjwmFb8zFY-1</gtr:outcomeId><gtr:partnerContribution>It is a globally unique comparison group for one of my research projects</gtr:partnerContribution><gtr:piContribution>I have designed the study that we will do in collaboration.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Academic Medical Center</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>PATCH collaboration with AMC</gtr:description><gtr:id>1B41F4D0-92CA-4536-BBB0-E988136AD81D</gtr:id><gtr:impact>Successful Chest Heart &amp;amp; Stroke Scotland project grant application</gtr:impact><gtr:outcomeId>eP812SKBURt-1</gtr:outcomeId><gtr:partnerContribution>Lead on randomised controlled trial</gtr:partnerContribution><gtr:piContribution>Membership of trial steering committee</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Oxford University Hospitals NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>NIHR Oxford Biomedical Research Centre</gtr:department><gtr:description>Collaboration with the Oxford Vascular Study</gtr:description><gtr:id>D229AC0C-3FB6-4422-9D67-FDF62B988D1F</gtr:id><gtr:impact>Publication in Brain, Pub Med ID 19042932</gtr:impact><gtr:outcomeId>9F450E964AF-1</gtr:outcomeId><gtr:partnerContribution>Joint analysis of our two cohorts, resulting in a publication in Brain</gtr:partnerContribution><gtr:piContribution>We led on the data analysis</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of California, San Francisco</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Center for Cerebrovascular Research</gtr:department><gtr:description>UCSF Center for Cerebrovascular Research</gtr:description><gtr:id>8BFE2A6B-B20F-417B-AC36-43D979881D54</gtr:id><gtr:impact>Applying to NIH as co-PI for funding of a randomised trial</gtr:impact><gtr:outcomeId>rm4JBj87zwN-1</gtr:outcomeId><gtr:piContribution>Intellectual contribution to design of a randomised controlled trial</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Presentations to patient organisations</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>3479EA5C-D7DE-44D7-97C4-525F9844A85F</gtr:id><gtr:impact>Patient education and information

Charitable funding (&amp;pound;20,000) was raised for the patient organisation as a result of my involvement.</gtr:impact><gtr:outcomeId>19084E9D04B</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Patients, carers and/or patient groups</gtr:primaryAudience><gtr:year>2007,2008,2009,2010,2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Participant newsletters</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>73D9580A-3797-4B1F-B7F3-DC454E514A68</gtr:id><gtr:impact>Annual newsletters to participants

Improved participant satisfaction</gtr:impact><gtr:outcomeId>7DC7B86ABBA</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Study participants or study members</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Written information leaflets for patient support organisations</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>F7F8CD08-EF07-4DFB-B4DD-6266E3FF47AD</gtr:id><gtr:impact>The first patient information leaflets for patients in the UK with this condition

Patients better informed. Grants awarded from the patient support organisation to underpin further similar activities</gtr:impact><gtr:outcomeId>P969MJ5Avv8</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2008,2009,2010,2011,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>SAIVMs open day</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>39339262-3811-46F4-A6DD-420D0E62A5C2</gtr:id><gtr:impact>150 study participants attended an open day to hear the results of the research and meet patient support groups

None</gtr:impact><gtr:outcomeId>gHhEaX9J1A4</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Neurosurgery department, Essen, Germany</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>18E90B61-1BFC-4D78-8973-BAA2836623C0</gtr:id><gtr:impact>Discussion of the design of a randomised controlled trial that could be run in Germany</gtr:impact><gtr:outcomeId>58c71205c15ff9.37071980</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk on management of intracranial vascular malformations</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>977D13EE-F747-40B8-AF2A-592C2C4BAFC1</gtr:id><gtr:impact>40 doctors attended my talk, which influenced their management of patients

I was invited to participate in an American Heart Association guidelines panel</gtr:impact><gtr:outcomeId>5456507683d4f3.03958632</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>2011 CCM workshop</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>CFE58F00-9A25-431C-A89F-8F0292E10A55</gtr:id><gtr:impact>Presentation of the first clinical guidelines for adults with cavernous malformations

Disseminated at Society of British Neurological Surgeons conference and prompted an invitation to speak at their subsequent meeting</gtr:impact><gtr:outcomeId>ZmceCuLenSm</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Event for participants in SAIVMs</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>67E459B8-9A6E-41C5-9F72-79DFA8A06331</gtr:id><gtr:impact>Whole day event for patients participating in my population-based study, involving patient support organisations

Further fundraising activities</gtr:impact><gtr:outcomeId>bZgUUW7QMms</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Clinical research fellow shortlisted for Max Perutz writing award</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>9301F6F0-1FA3-4DC4-AEF2-6182C4D128AC</gtr:id><gtr:impact>The clinical research fellow who I mentored and supervise on an MRC clinical research training fellowship was shortlisted for the MRC's Max Perutz writing award

Piece disseminated to participants in our research</gtr:impact><gtr:outcomeId>rmixjut1uM6</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>UK Neurovascular group</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>7AA1FCBF-2DBC-40E6-97DE-91DDF394D3A1</gtr:id><gtr:impact>Presentation of the breaking results of the ARUBA randomised controlled trial.

Practice-changing implications of the results</gtr:impact><gtr:outcomeId>FWMU1j1fHHM</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.arubastudy.org</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>109325</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Health Technology Assessment Programme (HTA)</gtr:department><gtr:description>CRASH-2 (Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage) IBS (Intracranial Bleeding Study): the effect of tranexamic acid on intracranial bleeding among CRASH-2 trial participants</gtr:description><gtr:end>2009-09-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:fundingRef>09/102/01</gtr:fundingRef><gtr:id>2AC5B36C-A355-423B-99B8-4D059DD24809</gtr:id><gtr:outcomeId>79CA7F412600</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>41463</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>A digital archive and web-based reviewing system for the imaging of intracranial vascular malformations: a tool to measure observer variation</gtr:description><gtr:end>2006-12-02</gtr:end><gtr:fundingOrg>Chief Scientist Office (CSO)</gtr:fundingOrg><gtr:fundingRef>CZG/2/265</gtr:fundingRef><gtr:id>EDD1171F-F552-4EA4-AD12-64BA6F996067</gtr:id><gtr:outcomeId>9229CCCEA370</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>167655</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Validation and phenotyping of stroke outcomes in UK Biobank</gtr:description><gtr:end>2013-12-02</gtr:end><gtr:fundingOrg>UK Biobank</gtr:fundingOrg><gtr:id>09F09BD9-BB49-4444-953C-524F413DB59F</gtr:id><gtr:outcomeId>MZsKgnLBJ3W0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>93000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>The genetic factors predisposing to brain arteriovenous malformations (BAVMs), and their effect on BAVM presentation, prognosis and response to treatment</gtr:description><gtr:end>2007-12-02</gtr:end><gtr:fundingOrg>Stroke Association</gtr:fundingOrg><gtr:fundingRef>TSA/2006/13</gtr:fundingRef><gtr:id>6C7FBBD2-B87E-4262-B5B0-504F4F24D98C</gtr:id><gtr:outcomeId>04B6D85C5C60</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>939718</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Microbleeds and genetic risk factors to predict the risk of intracranial haemorrhage in patients treated with anticoagulation following cardioembolic stroke due to AF</gtr:description><gtr:end>2016-05-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:fundingRef>TSA/BHF 2009/01</gtr:fundingRef><gtr:id>462331E4-3BB2-4D9A-8119-9C292939F030</gtr:id><gtr:outcomeId>32C7DA8766D0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>86985</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PATCH (Platelet Transfusion in Cerebral Haemorrhage)</gtr:description><gtr:end>2016-01-02</gtr:end><gtr:fundingOrg>Chest Heart &amp; Stroke Scotland</gtr:fundingOrg><gtr:fundingRef>Res10</gtr:fundingRef><gtr:id>76D258DD-7760-49D7-B0C5-641E8F33EAF3</gtr:id><gtr:outcomeId>jwRzWGSi6L30</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>300000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Part-funding for a research-dedicated 3 Tesla Magnetic Resonance (MR) Scanner</gtr:description><gtr:end>2015-12-02</gtr:end><gtr:fundingOrg>The Dunhill Medical Trust</gtr:fundingOrg><gtr:fundingRef>R380R/1114</gtr:fundingRef><gtr:id>26F9A2FF-76D1-4B07-9AF5-5684889D9E11</gtr:id><gtr:outcomeId>56b7bd010c2d11.00768533</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2105368</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC senior clinical fellowship: Cerebral amyloid angiopathy and intracerebral haemorrhage: community-based cohort study, biobank, and record linkage</gtr:description><gtr:end>2016-07-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>G1002605</gtr:fundingRef><gtr:id>6014C047-DFD6-46BE-A25B-C2FAFDAE4A52</gtr:id><gtr:outcomeId>ngpKTYJmuZH0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>202356</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC / Stroke Association clinical training fellowship (Neshika Samarasekera)</gtr:description><gtr:end>2013-02-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>G0900428</gtr:fundingRef><gtr:id>002B543B-F2CA-4222-95F4-44EA95D15D3E</gtr:id><gtr:outcomeId>54562a12a09b09.40737878</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-02-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>AVM review cited by BMJ Best Practice</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:guidelineTitle>Cerebral arteriovenous malformation</gtr:guidelineTitle><gtr:id>A47BD313-01B0-485D-9E00-06D71FC7142F</gtr:id><gtr:impact>Effective use of diagnostic and therapeutic techniques for brain arteriovenous malformations</gtr:impact><gtr:outcomeId>Wiu4FQxuoba</gtr:outcomeId><gtr:type>Citation in clinical guidelines</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>RCP London working party on research ethics</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>9D22F8F9-16EB-43A2-BCAD-C0DAECD8A13B</gtr:id><gtr:impact>Clear gudance on research ethics</gtr:impact><gtr:outcomeId>0C483F21323</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Citation in International League Against Epilepsy guidelines</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:guidelineTitle>Cavernoma-related epilepsy: Review and recommendations for management - Report of the Surgical Task Force of the ILAE Commission on Therapeutic Strategies</gtr:guidelineTitle><gtr:id>A9F9FDB6-45C0-4067-A10F-A7392A613CAF</gtr:id><gtr:impact>The risk of epilepsy after a first seizure relating to a cavernous malformation is so high that anti-epileptic drugs should be started without waiting for the second seizure</gtr:impact><gtr:outcomeId>k1sVPz9SYBp</gtr:outcomeId><gtr:type>Citation in clinical guidelines</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Stroke Research Network Prevention Clinical Studies Group</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>32BD7192-C521-43B4-9421-6475FC2BF810</gtr:id><gtr:impact>I was elected to the UK Stroke Research Network Prevention Clinical Studies Group to influence which research projects should be conducted in the UK</gtr:impact><gtr:outcomeId>L49Dqm6YiL6</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Project cited as an example of best practice in &amp;quot;A Manual for Caldicott Guardians&amp;quot; (Copyright 2017 UK Caldicott Guardian Council)</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>6E69ECFA-8D60-45A2-99CC-6AB49FFA34AE</gtr:id><gtr:impact>SAIVMs was cited by our local Caldicott Guardian as an example of audit and research which is integral to high quality prevention, treatment and care, and which has been done in &amp;quot;the right way.&amp;quot;</gtr:impact><gtr:outcomeId>58c43e57a159a7.66771960</gtr:outcomeId><gtr:type>Citation in other policy documents</gtr:type><gtr:url>https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/581213/cgmanual.pdf</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Citation in clinical practice guideline</gtr:description><gtr:geographicReach>Asia</gtr:geographicReach><gtr:guidelineTitle>Clinical Practice Guideline for the Management of Intracranial Aneurysms</gtr:guidelineTitle><gtr:id>A73AFEA8-F996-478B-9559-AD172FD59DB9</gtr:id><gtr:impact>Avoidance of use of magnesium treatment</gtr:impact><gtr:outcomeId>56e09651c907c7.39846877</gtr:outcomeId><gtr:type>Citation in clinical guidelines</gtr:type><gtr:url>http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4239410</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Department for Transport DVLA committee</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>FD6FDC46-9A89-4534-B1FA-CD5636AEF9F1</gtr:id><gtr:impact>My study was asked to provide data to inform the DVLA about their regulations on fitness to drive</gtr:impact><gtr:outcomeId>45510CB1A76</gtr:outcomeId><gtr:type>Gave evidence to a government review</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>British Neurological Surveillance Unit</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>E4F5404C-F650-439A-B35A-CFAE7027F3B4</gtr:id><gtr:outcomeId>0E026E289DA</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Appointment to American Heart Association guidelines committee for arteriovenous malformations of the brain</gtr:description><gtr:geographicReach>North America</gtr:geographicReach><gtr:id>CC99C181-9711-4AFD-B539-2C439680EE26</gtr:id><gtr:impact>Authorship of guidelines that will discourage the use of treatments that I showed in a recent clinical trial and population-based cohort to cause a three-fold increase in the risk of stroke in comparison to no treatment.</gtr:impact><gtr:outcomeId>54565c2f03ffe9.99237329</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Citation in European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:guidelineTitle>European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage</gtr:guidelineTitle><gtr:id>080D41AB-5C47-43FC-88D9-7ED689316B20</gtr:id><gtr:impact>Importance of avoidance of haemostatic drugs in spontaneous ICH not associated with antithrombotic drug use</gtr:impact><gtr:outcomeId>54565b33f2cba1.54628407</gtr:outcomeId><gtr:type>Citation in clinical guidelines</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>European guidelines on intracerebral haemorrhage</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>05E3B756-A750-4192-8413-14B2B98A09F1</gtr:id><gtr:impact>Guidance to practitioners based on the best available evidence in clinical trials.</gtr:impact><gtr:outcomeId>JKcarULuCES</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type><gtr:url>http://onlinelibrary.wiley.com/store/10.1111/ijs.12309/asset/ijs12309.pdf?v=1&amp;t=i20li2eq&amp;s=ec8a26db9809ef59b6b77088271fb22fc20eac80</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Revision of the Adults With Incapacity (Scotland) Act 2000</gtr:description><gtr:geographicReach>Local/Municipal/Regional</gtr:geographicReach><gtr:id>B3E26986-1CD6-44DF-B5A4-407A403ADB7C</gtr:id><gtr:impact>As a result of the difficulties I experienced with gaining research ethics committee approval for my research with the only research ethics committee allowed to adjudicate it in Scotland, I campaigned for applicants to have the right to appeal. The Government subsequently consulted on this change, and it looks likely to be progressing.</gtr:impact><gtr:outcomeId>aviKozPrLNz</gtr:outcomeId><gtr:type>Gave evidence to a government review</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Clinical, radiological, and DNA repository from adults with intracranial vascular malformations</gtr:description><gtr:id>AC55D8E5-CA91-4F86-BD7A-9FBADBF28070</gtr:id><gtr:impact>Multiple publications</gtr:impact><gtr:outcomeId>A86A928DEC7</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Biobank of adults with intracranial vascular malformations</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Web-based system for review and data collection from a variety of neuroradiological imaging techniques</gtr:description><gtr:id>B5145834-3ECD-46A3-9079-D8492EF9F3CE</gtr:id><gtr:impact>Data collection to validate patients included in a population-based disease register, and collect data for a study on inter-rater reliability</gtr:impact><gtr:outcomeId>0FA38BC410B</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Web-based imaging review system</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Community-based study of adults with intracerebral haemorrhage</gtr:description><gtr:id>B5116995-07BB-4FEC-9D1B-6F9D6823712A</gtr:id><gtr:impact>Collaboration with MRC Cognitive Function and Ageing Study in place for unique future analyses</gtr:impact><gtr:outcomeId>VCJjkBnqBu2</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Biobank of data, imaging, and tissue from patients with intracerebral haemorrhage</gtr:title><gtr:type>Biological samples</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>DCE9F06F-1BFF-41A2-AD60-C6C1659B27B4</gtr:id><gtr:title>European research priorities for intracerebral haemorrhage.</gtr:title><gtr:parentPublicationTitle>Cerebrovascular diseases (Basel, Switzerland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aff88f0b872ddcb9447fb172425aa2bd"><gtr:id>aff88f0b872ddcb9447fb172425aa2bd</gtr:id><gtr:otherNames>Steiner T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1015-9770</gtr:issn><gtr:outcomeId>tkrQf2F5NDm</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>893A7889-25D0-4711-B34E-A1A3B465BC37</gtr:id><gtr:title>Brain MRI roulette.</gtr:title><gtr:parentPublicationTitle>Practical neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/465202a0e76a70c877a9acff11c95c35"><gtr:id>465202a0e76a70c877a9acff11c95c35</gtr:id><gtr:otherNames>Al-Shahi Salman R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1474-7758</gtr:issn><gtr:outcomeId>cLGSozbcgGk</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D275E1D3-9AE1-4075-AF40-15510DBBEC87</gtr:id><gtr:title>Research governance impediments to clinical trials: a retrospective survey.</gtr:title><gtr:parentPublicationTitle>Journal of the Royal Society of Medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/465202a0e76a70c877a9acff11c95c35"><gtr:id>465202a0e76a70c877a9acff11c95c35</gtr:id><gtr:otherNames>Al-Shahi Salman R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0141-0768</gtr:issn><gtr:outcomeId>2FE31020857</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D7169844-FE26-4AE5-AD7A-52CCFC960710</gtr:id><gtr:title>Radiological investigation of spontaneous intracerebral hemorrhage: systematic review and trinational survey.</gtr:title><gtr:parentPublicationTitle>Stroke</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ae7d0f30486fd0e8dcdf6acde8aa534b"><gtr:id>ae7d0f30486fd0e8dcdf6acde8aa534b</gtr:id><gtr:otherNames>Cordonnier C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0039-2499</gtr:issn><gtr:outcomeId>c5cgrMBRFDe</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>14A816A8-A344-4EA5-AC59-C1247F33CBA1</gtr:id><gtr:title>Comment on &amp;quot;Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome&amp;quot;.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/56022eb4712f9703d94edab35e2b236b"><gtr:id>56022eb4712f9703d94edab35e2b236b</gtr:id><gtr:otherNames>Sudlow C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>G1zwZPKkxYZ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>493FF7C3-FFDE-4927-927C-AAD3D6DF1260</gtr:id><gtr:title>The persisting burden of intracerebral haemorrhage: can effective treatments be found?</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e24829623af116319f10a210db3a6f44"><gtr:id>e24829623af116319f10a210db3a6f44</gtr:id><gtr:otherNames>Josephson CB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>WasZxydPsPG</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B4308119-4F66-4CDC-AF7C-91664D4E9DB4</gtr:id><gtr:title>Spontaneous brain microbleeds: systematic review, subgroup analyses and standards for study design and reporting.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ae7d0f30486fd0e8dcdf6acde8aa534b"><gtr:id>ae7d0f30486fd0e8dcdf6acde8aa534b</gtr:id><gtr:otherNames>Cordonnier C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>4E2D895789C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D28CF762-0F83-4896-9C77-E84F98904F98</gtr:id><gtr:title>The ARUBA trial: current status, future hopes.</gtr:title><gtr:parentPublicationTitle>Stroke</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/310a48a6d49f39ef71b7decfc3126e79"><gtr:id>310a48a6d49f39ef71b7decfc3126e79</gtr:id><gtr:otherNames>Mohr JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0039-2499</gtr:issn><gtr:outcomeId>H1JhgXADPJw</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B99AE2F1-831E-4324-B2D4-628FBCDDD311</gtr:id><gtr:title>Hemorrhage from cavernous malformations of the brain: definition and reporting standards. Angioma Alliance Scientific Advisory Board.</gtr:title><gtr:parentPublicationTitle>Stroke</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/465202a0e76a70c877a9acff11c95c35"><gtr:id>465202a0e76a70c877a9acff11c95c35</gtr:id><gtr:otherNames>Al-Shahi Salman R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0039-2499</gtr:issn><gtr:outcomeId>765414F1419</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>11F9E8A3-8F24-474E-9AE0-B6444E9704EA</gtr:id><gtr:title>Treatment of intracerebral hemorrhage in animal models: meta-analysis.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/033bde0f5fa064b896003a2d2860e6b9"><gtr:id>033bde0f5fa064b896003a2d2860e6b9</gtr:id><gtr:otherNames>Frantzias J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>qBRwh6jT4iW</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A9ABC6F9-A975-4FF6-B4DD-2BC8CCC87A30</gtr:id><gtr:title>Acute neurological problems: frequency, consultation patterns and the uses of a rapid access neurology clinic.</gtr:title><gtr:parentPublicationTitle>The journal of the Royal College of Physicians of Edinburgh</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c477019987ebba659353c0cae0459d32"><gtr:id>c477019987ebba659353c0cae0459d32</gtr:id><gtr:otherNames>Chapman FA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1478-2715</gtr:issn><gtr:outcomeId>QZFnm9N7Ghn</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2E7B41E9-9F7B-4AB8-8FE6-68EBC32E10E4</gtr:id><gtr:title>Economic burden of intracranial vascular malformations in adults: prospective population-based study.</gtr:title><gtr:parentPublicationTitle>Stroke</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/22627e6001d74fb72ddea52c3a438e64"><gtr:id>22627e6001d74fb72ddea52c3a438e64</gtr:id><gtr:otherNames>Miller CE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0039-2499</gtr:issn><gtr:outcomeId>0BA6A2CA644</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C21BB2CF-DB3D-4399-AFB5-34FE5A183512</gtr:id><gtr:title>Neurological picture. Double depressor palsy caused by bilateral paramedian thalamic infarcts.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/abb63d4d9b9db03c1df4483293dd45c9"><gtr:id>abb63d4d9b9db03c1df4483293dd45c9</gtr:id><gtr:otherNames>Pal S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>P58Xac2J9Yz</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>87CA00A0-CE24-4695-8C74-E2C8F40F62EA</gtr:id><gtr:title>Management of brain arteriovenous malformations.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/465202a0e76a70c877a9acff11c95c35"><gtr:id>465202a0e76a70c877a9acff11c95c35</gtr:id><gtr:otherNames>Al-Shahi Salman R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>54561bda409ed8.93825463</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>889A0B0F-CC3D-4AE5-B929-3D482899B746</gtr:id><gtr:title>Top ten research priorities for brain and spine cavernous malformations</gtr:title><gtr:parentPublicationTitle>LANCET NEUROLOGY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/900ed6ab3beef196773fd6cff638785b"><gtr:id>900ed6ab3beef196773fd6cff638785b</gtr:id><gtr:otherNames>Salman Rustam Al-Shahi</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>5a3602c96c0c17.23978255</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3C083A8E-7CFB-411A-8167-E24CD2B8399D</gtr:id><gtr:title>Haemostatic drug therapies for acute spontaneous intracerebral haemorrhage.</gtr:title><gtr:parentPublicationTitle>The Cochrane database of systematic reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/465202a0e76a70c877a9acff11c95c35"><gtr:id>465202a0e76a70c877a9acff11c95c35</gtr:id><gtr:otherNames>Al-Shahi Salman R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1361-6137</gtr:issn><gtr:outcomeId>90974DC4668</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>30D24966-409F-4616-B33B-7FD342B92282</gtr:id><gtr:title>Outcome after spontaneous and arteriovenous malformation-related intracerebral haemorrhage: population-based studies.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/49bfd50d3d2df0cefb65c8f203b6e56b"><gtr:id>49bfd50d3d2df0cefb65c8f203b6e56b</gtr:id><gtr:otherNames>van Beijnum J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>88EA6E00F78</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EC050748-E18E-4917-A1F2-1FBAEBB78AC5</gtr:id><gtr:title>Evaluation of excess significance bias in animal studies of neurological diseases.</gtr:title><gtr:parentPublicationTitle>PLoS biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/152b16a02def31f110d90fe64c93d499"><gtr:id>152b16a02def31f110d90fe64c93d499</gtr:id><gtr:otherNames>Tsilidis KK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1544-9173</gtr:issn><gtr:outcomeId>pm_12571_21_23874156</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CA1844D3-54F7-47DB-B5AE-508337E23DFC</gtr:id><gtr:title>Early Magnesium Treatment After Aneurysmal Subarachnoid Hemorrhage: Individual Patient Data Meta-Analysis.</gtr:title><gtr:parentPublicationTitle>Stroke</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/324b1e1df09141f985ccd5529c03abfd"><gtr:id>324b1e1df09141f985ccd5529c03abfd</gtr:id><gtr:otherNames>Dorhout Mees SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0039-2499</gtr:issn><gtr:outcomeId>56b7b7cbbf06a1.92261153</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F8A6E355-9BC0-4FD3-8F64-591B6333E769</gtr:id><gtr:title>An episode of transient neurological symptoms.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e24829623af116319f10a210db3a6f44"><gtr:id>e24829623af116319f10a210db3a6f44</gtr:id><gtr:otherNames>Josephson CB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>8081566F2C8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AFC1FFCB-D2DB-4D9A-BD19-2D765E0CA436</gtr:id><gtr:title>Recruitment difficulties in brain tumour patients cause participation bias: findings from a neuropsychological study of adult inpatients with supratentorial intracranial tumours.</gtr:title><gtr:parentPublicationTitle>Acta neurochirurgica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1b2eb7bb76eb963eadbab2f9c817ecfc"><gtr:id>1b2eb7bb76eb963eadbab2f9c817ecfc</gtr:id><gtr:otherNames>Scotland JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0001-6268</gtr:issn><gtr:outcomeId>8DB53C07420</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E6C73202-9A19-4E40-AE35-DAA19105B69F</gtr:id><gtr:title>Quality of life and disability 12 months after surgery vs. conservative management for unruptured brain arteriovenous malformations: Scottish population-based and Australian hospital-based studies.</gtr:title><gtr:parentPublicationTitle>Acta neurochirurgica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b6ce24dad099922574199e57404e6520"><gtr:id>b6ce24dad099922574199e57404e6520</gtr:id><gtr:otherNames>O'Donnell JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0001-6268</gtr:issn><gtr:outcomeId>5aa44d66dcc0d5.94710718</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>754AFB50-211B-4E85-A07D-A494BD55C6DA</gtr:id><gtr:title>Intracranial Vascular Malformations and Epilepsy.</gtr:title><gtr:parentPublicationTitle>Seminars in neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e24829623af116319f10a210db3a6f44"><gtr:id>e24829623af116319f10a210db3a6f44</gtr:id><gtr:otherNames>Josephson CB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0271-8235</gtr:issn><gtr:outcomeId>56b7b7cc891202.98407407</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EACC4CC8-9306-4FE2-9801-799925398771</gtr:id><gtr:title>Conservative management vs intervention for unruptured brain arteriovenous malformations--reply.</gtr:title><gtr:parentPublicationTitle>JAMA</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/465202a0e76a70c877a9acff11c95c35"><gtr:id>465202a0e76a70c877a9acff11c95c35</gtr:id><gtr:otherNames>Al-Shahi Salman R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0098-7484</gtr:issn><gtr:outcomeId>54561bdbab9912.72087840</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F8A10E68-A5A0-4291-AABE-39DED46B79F6</gtr:id><gtr:title>Outcome after conservative management or intervention for unruptured brain arteriovenous malformations.</gtr:title><gtr:parentPublicationTitle>JAMA</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/465202a0e76a70c877a9acff11c95c35"><gtr:id>465202a0e76a70c877a9acff11c95c35</gtr:id><gtr:otherNames>Al-Shahi Salman R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0098-7484</gtr:issn><gtr:outcomeId>pm_540e179e179260532</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EA35E2DA-A047-4827-967B-675CF1B3B88F</gtr:id><gtr:title>What do patients think about appearing in neurology &amp;quot;grand rounds&amp;quot;?</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/465202a0e76a70c877a9acff11c95c35"><gtr:id>465202a0e76a70c877a9acff11c95c35</gtr:id><gtr:otherNames>Al-Shahi Salman R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>0E1AA66EB02</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>596336C6-00AD-4908-B528-50C33922C9D9</gtr:id><gtr:title>Genome-wide association study of sporadic brain arteriovenous malformations.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a2a13fee4dd46dddbcbaca29dbc5d471"><gtr:id>a2a13fee4dd46dddbcbaca29dbc5d471</gtr:id><gtr:otherNames>Weinsheimer S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>56b7b7ca6f6c32.06600601</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7FDE5AAB-0749-403F-BF14-320305E198CB</gtr:id><gtr:title>Unlocking the 'locked-in syndrome'.</gtr:title><gtr:parentPublicationTitle>British journal of neurosurgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/218d288a76622e97adecd20d932727ee"><gtr:id>218d288a76622e97adecd20d932727ee</gtr:id><gtr:otherNames>Shanmuganathan M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0268-8697</gtr:issn><gtr:outcomeId>VfhxHWAhaYa</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2E5C9678-520F-4350-B0C8-56CC58501EAA</gtr:id><gtr:title>Outcome after surgical or conservative management of cerebral cavernous malformations.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5c1dbb5b22be0db92a6593a4bc58d4bb"><gtr:id>5c1dbb5b22be0db92a6593a4bc58d4bb</gtr:id><gtr:otherNames>Moultrie F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>54561bda97fea3.28581997</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>33B8B939-3771-46AC-B69A-CEEA71C24D41</gtr:id><gtr:title>Differences between intracranial vascular malformation types in the characteristics of their presenting haemorrhages: prospective, population-based study.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ae7d0f30486fd0e8dcdf6acde8aa534b"><gtr:id>ae7d0f30486fd0e8dcdf6acde8aa534b</gtr:id><gtr:otherNames>Cordonnier C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>345E9A3828A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>421DCBD4-7EDB-41B4-BC8C-9F6B85610CDA</gtr:id><gtr:title>Treatment of cerebral cavernous malformations: a systematic review and meta-regression analysis.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/abf51cb12a6636f924cd773d527dc2c8"><gtr:id>abf51cb12a6636f924cd773d527dc2c8</gtr:id><gtr:otherNames>Poorthuis MH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>54174c1f192817.59473536</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>351B485B-7D94-47CD-926C-F8FA2D26D391</gtr:id><gtr:title>Cerebral microbleeds: a guide to detection and interpretation.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ec5f1e11b86ec0689918d02280094d1a"><gtr:id>ec5f1e11b86ec0689918d02280094d1a</gtr:id><gtr:otherNames>Greenberg SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>72E6403CD87</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>562B5913-8E82-4861-A789-6E4AD3432F96</gtr:id><gtr:title>Seizure risk from cavernous or arteriovenous malformations: prospective population-based study.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e24829623af116319f10a210db3a6f44"><gtr:id>e24829623af116319f10a210db3a6f44</gtr:id><gtr:otherNames>Josephson CB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>ZHsStTp4bmU</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8CDC2AC9-D49F-46E8-A411-35C5A0DFE4DB</gtr:id><gtr:title>Management of brain arteriovenous malformations</gtr:title><gtr:parentPublicationTitle>LANCET</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/900ed6ab3beef196773fd6cff638785b"><gtr:id>900ed6ab3beef196773fd6cff638785b</gtr:id><gtr:otherNames>Salman Rustam Al-Shahi</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>5a3517d43c7b88.86997253</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A9EDE26E-90F6-44C7-AC3A-476317A7905C</gtr:id><gtr:title>Clinical course of untreated cerebral cavernous malformations: a meta-analysis of individual patient data.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/db42d1cfaf0a5fe581d96d1e71804ae3"><gtr:id>db42d1cfaf0a5fe581d96d1e71804ae3</gtr:id><gtr:otherNames>Horne MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>56dff604758506.98909287</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AD303EA1-4B0B-4AB9-946F-2C3AAE7E0568</gtr:id><gtr:title>Patterns of brain arteriovenous malformation treatment: prospective, population-based study.</gtr:title><gtr:parentPublicationTitle>Stroke</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/49bfd50d3d2df0cefb65c8f203b6e56b"><gtr:id>49bfd50d3d2df0cefb65c8f203b6e56b</gtr:id><gtr:otherNames>van Beijnum J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0039-2499</gtr:issn><gtr:outcomeId>7486D81B23B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6633024D-B0A5-4AF2-A58A-6D6865C2B506</gtr:id><gtr:title>Delayed diagnosis of oculopharyngeal muscular dystrophy in Scotland.</gtr:title><gtr:parentPublicationTitle>The British journal of ophthalmology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8225020d9508e613bd1f27ed66c83a62"><gtr:id>8225020d9508e613bd1f27ed66c83a62</gtr:id><gtr:otherNames>Agarwal PK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0007-1161</gtr:issn><gtr:outcomeId>Jyv4Zf8GASZ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>010748FC-AFEF-44BC-8F8B-517ECADB9871</gtr:id><gtr:title>Effect of tranexamic acid in traumatic brain injury: a nested randomised, placebo controlled trial (CRASH-2 Intracranial Bleeding Study).</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5956bc76aa29ea93d4a7329fab0e4fa9"><gtr:id>5956bc76aa29ea93d4a7329fab0e4fa9</gtr:id><gtr:otherNames>CRASH-2 Collaborators, Intracranial Bleeding Study</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>rbKmrcYHvG4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>176E67ED-6774-4D40-A20B-061CBE4B03F6</gtr:id><gtr:title>Research governance impediments to clinical trials: a retrospective survey</gtr:title><gtr:parentPublicationTitle>JOURNAL OF THE ROYAL SOCIETY OF MEDICINE</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/900ed6ab3beef196773fd6cff638785b"><gtr:id>900ed6ab3beef196773fd6cff638785b</gtr:id><gtr:otherNames>Salman Rustam Al-Shahi</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0141-0768</gtr:issn><gtr:outcomeId>5a3601cae53163.45274536</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BDC3AD71-E137-4C83-B7B5-F5821FF59707</gtr:id><gtr:title>Autoimmune limbic encephalitis.</gtr:title><gtr:parentPublicationTitle>Clinical medicine (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4384aa146a95139ee79cee6856143a5f"><gtr:id>4384aa146a95139ee79cee6856143a5f</gtr:id><gtr:otherNames>Derry CP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1470-2118</gtr:issn><gtr:outcomeId>L8duqEPsjHK</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2D91F093-325A-428F-B2F9-CE253CA3F925</gtr:id><gtr:title>improving interrater agreement about brain microbleeds: development of the Brain Observer MicroBleed Scale (BOMBS).</gtr:title><gtr:parentPublicationTitle>Stroke</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ae7d0f30486fd0e8dcdf6acde8aa534b"><gtr:id>ae7d0f30486fd0e8dcdf6acde8aa534b</gtr:id><gtr:otherNames>Cordonnier C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0039-2499</gtr:issn><gtr:outcomeId>8CEC15A0BF3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3D19DB9F-1B74-4B2C-BF44-63320F78FBBB</gtr:id><gtr:title>The presentation and clinical course of intracranial developmental venous anomalies in adults: a systematic review and prospective, population-based study.</gtr:title><gtr:parentPublicationTitle>Stroke</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/63e9c71d4b54ef75a37ff37f334143d0"><gtr:id>63e9c71d4b54ef75a37ff37f334143d0</gtr:id><gtr:otherNames>Hon JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0039-2499</gtr:issn><gtr:outcomeId>99543B33F7A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E9797782-6FC7-4C23-ADF9-0143158EDDA1</gtr:id><gtr:title>Genetic associations with brain microbleeds: Systematic review and meta-analyses.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cc753abfdb4d307f8a61af0db22bf227"><gtr:id>cc753abfdb4d307f8a61af0db22bf227</gtr:id><gtr:otherNames>Maxwell SS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>AtBCQXEUgrv</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7AD6B068-AFCD-442B-A9C9-756AFC3B28F1</gtr:id><gtr:title>Subarachnoid haemorrhage.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/326c6c0d68ed817107ba66a832ff4dbb"><gtr:id>326c6c0d68ed817107ba66a832ff4dbb</gtr:id><gtr:otherNames>Al-Shahi R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>0F52B5721D2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C3D40F20-FF0D-430D-8C30-0AE770C131AB</gtr:id><gtr:title>Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trial.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/324b1e1df09141f985ccd5529c03abfd"><gtr:id>324b1e1df09141f985ccd5529c03abfd</gtr:id><gtr:otherNames>Dorhout Mees SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>pm_12571_21_22633825</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>321C5C11-BC16-4FBA-AF79-5F20C928A6CC</gtr:id><gtr:title>Interventions for treating brain arteriovenous malformations in adults.</gtr:title><gtr:parentPublicationTitle>The Cochrane database of systematic reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/326c6c0d68ed817107ba66a832ff4dbb"><gtr:id>326c6c0d68ed817107ba66a832ff4dbb</gtr:id><gtr:otherNames>Al-Shahi R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1361-6137</gtr:issn><gtr:outcomeId>FC03D024790</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>77477C50-685F-474F-BFCE-D4F4F0BAC270</gtr:id><gtr:title>Statistical analysis plan for the PlAtelet Transfusion in Cerebral Haemorrhage (PATCH) trial: a multicentre randomised controlled trial.</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/733a5144245cb5843fc2d27daf7c603c"><gtr:id>733a5144245cb5843fc2d27daf7c603c</gtr:id><gtr:otherNames>Baharoglu MI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn><gtr:outcomeId>585d6a36589726.02679780</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E4F8722A-3225-4C99-BCD4-EA86AEC525E8</gtr:id><gtr:title>Screening patients with a family history of subarachnoid haemorrhage for intracranial aneurysms: screening uptake, patient characteristics and outcome.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d9766ae97824f6de14e15ac9f7dd46f9"><gtr:id>d9766ae97824f6de14e15ac9f7dd46f9</gtr:id><gtr:otherNames>Miller TD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>CNfF5rq7TAU</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3321672D-C399-4B7E-8AE4-0D56E889B08C</gtr:id><gtr:title>Guillain-Barr&amp;eacute; syndrome and H1N1 (2009) pandemic influenza vaccination using an AS03 adjuvanted vaccine in the United Kingdom: self-controlled case series.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/71953361aa1127e81edfcbb2798c99aa"><gtr:id>71953361aa1127e81edfcbb2798c99aa</gtr:id><gtr:otherNames>Andrews N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>ZMtSe5BkAZb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1A8E1570-902C-49CD-8CED-D20A6129FBCD</gtr:id><gtr:title>Antithrombotic drug use, cerebral microbleeds, and intracerebral hemorrhage: a systematic review of published and unpublished studies.</gtr:title><gtr:parentPublicationTitle>Stroke</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4931daada770a5081020b1b2aa8b52b5"><gtr:id>4931daada770a5081020b1b2aa8b52b5</gtr:id><gtr:otherNames>Lovelock CE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0039-2499</gtr:issn><gtr:outcomeId>PyKvfciZeYm</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4E258D94-705C-4705-A3E9-8F0034701F3D</gtr:id><gtr:title>Haemostatic drug therapies for acute primary intracerebral haemorrhage.</gtr:title><gtr:parentPublicationTitle>The Cochrane database of systematic reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3d76e27bf0862276981625a5b02cc90f"><gtr:id>3d76e27bf0862276981625a5b02cc90f</gtr:id><gtr:otherNames>You H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1361-6137</gtr:issn><gtr:outcomeId>300BE83F51C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>96C5855E-F19A-4BC5-8009-037C9D694506</gtr:id><gtr:title>The frequency of thrombotic events among adults given antifibrinolytic drugs for spontaneous bleeding: systematic review and meta-analysis of observational studies and randomized trials.</gtr:title><gtr:parentPublicationTitle>Current drug safety</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b90fcb86f8ff0ef88ec4421190f7ff22"><gtr:id>b90fcb86f8ff0ef88ec4421190f7ff22</gtr:id><gtr:otherNames>Ross J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1574-8863</gtr:issn><gtr:outcomeId>pm_12571_21_22663958</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0DD3D610-6DC1-48AB-8A19-67121D02E0DD</gtr:id><gtr:title>Computed Tomographic Angiography or Magnetic Resonance Angiography for Detection of Intracranial Vascular Malformations in Patients With Intracerebral Hemorrhage</gtr:title><gtr:parentPublicationTitle>Stroke</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0e035c2b527e04d6157cafb7d0806ff9"><gtr:id>0e035c2b527e04d6157cafb7d0806ff9</gtr:id><gtr:otherNames>Josephson C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>5aa44d691056b2.03026138</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>082D116A-7FBE-45F5-BB85-0CF99329B3E0</gtr:id><gtr:title>Prognosis and treatment of intracranial dural arteriovenous fistulae: a systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>International journal of stroke : official journal of the International Stroke Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/33342a95a5440ee213f0804af9129157"><gtr:id>33342a95a5440ee213f0804af9129157</gtr:id><gtr:otherNames>Kobayashi A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1747-4930</gtr:issn><gtr:outcomeId>54561bdae1fd33.96304133</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F37D92E1-DCEE-449E-9A8B-65FB386A3F35</gtr:id><gtr:title>Untreated brain arteriovenous malformation: patient-level meta-analysis of hemorrhage predictors.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/30090b6ac8e7835f0dcaf37d05926960"><gtr:id>30090b6ac8e7835f0dcaf37d05926960</gtr:id><gtr:otherNames>Kim H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>54561bdabddbf0.71611470</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8016EE23-A773-4501-A449-7722DE0E1851</gtr:id><gtr:title>Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/066e8441fd42345774dc20f242b1e83c"><gtr:id>066e8441fd42345774dc20f242b1e83c</gtr:id><gtr:otherNames>Morris Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>BE45C1C3151</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>41B67700-33F6-4974-ADAD-806749DB54FE</gtr:id><gtr:title>Top ten research priorities for brain and spine cavernous malformations.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/465202a0e76a70c877a9acff11c95c35"><gtr:id>465202a0e76a70c877a9acff11c95c35</gtr:id><gtr:otherNames>Al-Shahi Salman R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>58c43779b38307.90808507</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B54CBEB5-1198-4E84-A252-992FB5E3B0AF</gtr:id><gtr:title>Untreated clinical course of cerebral cavernous malformations: a prospective, population-based cohort study.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/465202a0e76a70c877a9acff11c95c35"><gtr:id>465202a0e76a70c877a9acff11c95c35</gtr:id><gtr:otherNames>Al-Shahi Salman R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>pm_12571_21_22297119</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FA798204-55F1-4AAE-8690-231C274D04A3</gtr:id><gtr:title>Interventions for treating brain arteriovenous malformations in adults.</gtr:title><gtr:parentPublicationTitle>The Cochrane database of systematic reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b90fcb86f8ff0ef88ec4421190f7ff22"><gtr:id>b90fcb86f8ff0ef88ec4421190f7ff22</gtr:id><gtr:otherNames>Ross J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1361-6137</gtr:issn><gtr:outcomeId>ZGbjHkaySPs</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>20A08065-6F7D-4604-8BC6-F8EA65FF89E4</gtr:id><gtr:title>CSF opening pressure: reference interval and the effect of body mass index.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e0e5e9cd102979ad42c3c043c5c1088d"><gtr:id>e0e5e9cd102979ad42c3c043c5c1088d</gtr:id><gtr:otherNames>Whiteley W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>3D7EA9C69AA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>619D37AC-9EA8-44BD-AB4D-77D166E99247</gtr:id><gtr:title>The next step in understanding the prognosis of cerebral cavernous malformations.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/465202a0e76a70c877a9acff11c95c35"><gtr:id>465202a0e76a70c877a9acff11c95c35</gtr:id><gtr:otherNames>Al-Shahi Salman R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>pm_12571_21_22302544</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>41C535C1-A4FD-4658-87C6-134E6C041A0F</gtr:id><gtr:title>Spontaneous intracerebral haemorrhage.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/465202a0e76a70c877a9acff11c95c35"><gtr:id>465202a0e76a70c877a9acff11c95c35</gtr:id><gtr:otherNames>Al-Shahi Salman R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>D7A7CAEAA83</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FA08E152-870B-4F11-816E-85BFD90323CC</gtr:id><gtr:title>CRASH-2 (Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage) intracranial bleeding study: the effect of tranexamic acid in traumatic brain injury--a nested randomised, placebo-controlled trial.</gtr:title><gtr:parentPublicationTitle>Health technology assessment (Winchester, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cfd8c267b78cf5a764bc4ee22e4f0a1e"><gtr:id>cfd8c267b78cf5a764bc4ee22e4f0a1e</gtr:id><gtr:otherNames>Perel P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1366-5278</gtr:issn><gtr:outcomeId>pm_12571_21_22417901</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DFCC6503-35E9-4F9A-BCFF-DED6557184F0</gtr:id><gtr:title>Stroke due to a cardiac myxoma.</gtr:title><gtr:parentPublicationTitle>Practical neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/465202a0e76a70c877a9acff11c95c35"><gtr:id>465202a0e76a70c877a9acff11c95c35</gtr:id><gtr:otherNames>Al-Shahi Salman R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1474-7758</gtr:issn><gtr:outcomeId>E8AB70AA264</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B9866FE4-3915-411D-9F58-DBAF892A7F2B</gtr:id><gtr:title>Emergency department evaluation of sudden, severe headache.</gtr:title><gtr:parentPublicationTitle>QJM : monthly journal of the Association of Physicians</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ddb0b0dc89c058b4bdfb32f1abb14bc"><gtr:id>8ddb0b0dc89c058b4bdfb32f1abb14bc</gtr:id><gtr:otherNames>Breen DP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1460-2393</gtr:issn><gtr:outcomeId>EEF800029A2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8DD6CD31-94F4-457D-8F25-1F149AA0E91C</gtr:id><gtr:title>Seizure risk with AVM treatment or conservative management: prospective, population-based study.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e24829623af116319f10a210db3a6f44"><gtr:id>e24829623af116319f10a210db3a6f44</gtr:id><gtr:otherNames>Josephson CB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>pm_12571_21_22764257</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5B174310-47AC-45C8-89C1-905868B6C5DD</gtr:id><gtr:title>Outcome after interventional or conservative management of unruptured brain arteriovenous malformations: a prospective, population-based cohort study.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7f08aa7940dc2a54aa0ed8a82d6c5836"><gtr:id>7f08aa7940dc2a54aa0ed8a82d6c5836</gtr:id><gtr:otherNames>Wedderburn CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>766CC349EC0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7DF6C4B2-61D3-49E0-A4C9-DBD815F9E25C</gtr:id><gtr:title>Treatment of brain arteriovenous malformations: a systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>JAMA</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/49bfd50d3d2df0cefb65c8f203b6e56b"><gtr:id>49bfd50d3d2df0cefb65c8f203b6e56b</gtr:id><gtr:otherNames>van Beijnum J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0098-7484</gtr:issn><gtr:outcomeId>VTN3vePpgb4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6BA4D208-D5C4-4B82-A2E8-C36669B44A26</gtr:id><gtr:title>The outlook for adults with epileptic seizure(s) associated with cerebral cavernous malformations or arteriovenous malformations.</gtr:title><gtr:parentPublicationTitle>Epilepsia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/465202a0e76a70c877a9acff11c95c35"><gtr:id>465202a0e76a70c877a9acff11c95c35</gtr:id><gtr:otherNames>Al-Shahi Salman R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0013-9580</gtr:issn><gtr:outcomeId>pm_12571_21_22946719</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>938C4240-11C4-480D-BD4F-E25C9BD0501B</gtr:id><gtr:title>Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/733a5144245cb5843fc2d27daf7c603c"><gtr:id>733a5144245cb5843fc2d27daf7c603c</gtr:id><gtr:otherNames>Baharoglu MI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>585d502545a9d4.72445714</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>475EBCBD-F577-4C56-A2A1-817567DEB695</gtr:id><gtr:title>The association between cerebral amyloid angiopathy and intracerebral haemorrhage: systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2c861e8d45520a106ad49e9bda308d7b"><gtr:id>2c861e8d45520a106ad49e9bda308d7b</gtr:id><gtr:otherNames>Samarasekera N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>X7317tpEswv</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3696DA18-0691-4860-8A39-7CD8D96C347D</gtr:id><gtr:title>Conservative Management vs Intervention for Unruptured Brain Arteriovenous Malformations Reply</gtr:title><gtr:parentPublicationTitle>JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/900ed6ab3beef196773fd6cff638785b"><gtr:id>900ed6ab3beef196773fd6cff638785b</gtr:id><gtr:otherNames>Salman Rustam Al-Shahi</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0098-7484</gtr:issn><gtr:outcomeId>5a3518bd1eeb21.30141680</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>50DF644E-9A25-480E-B23D-549AAAB9767C</gtr:id><gtr:title>The unruptured intracranial aneurysm treatment score: a multidisciplinary consensus.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7ad5aecaf2a18378f9020b9030625195"><gtr:id>7ad5aecaf2a18378f9020b9030625195</gtr:id><gtr:otherNames>Etminan N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>56b7b7cc1ce855.79437474</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BA7AFBA8-757E-4607-BFB5-524BA2B9995E</gtr:id><gtr:title>Relative risk of hemorrhage during pregnancy in patients with brain arteriovenous malformations.</gtr:title><gtr:parentPublicationTitle>International journal of stroke : official journal of the International Stroke Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/49bfd50d3d2df0cefb65c8f203b6e56b"><gtr:id>49bfd50d3d2df0cefb65c8f203b6e56b</gtr:id><gtr:otherNames>van Beijnum J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1747-4930</gtr:issn><gtr:outcomeId>5aa44d687407e7.68347749</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G108/613</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>A77DAE3A-499B-4F46-971D-6C82F51F9C2E</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Stroke</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>9A8BEDCC-D902-4C9A-8CCF-C974265EA3FB</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.4  Surveillance and distribution</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>